Oral Delivery of Tocotrienols: Addressing Pharmacokinetic Challenges With Formulation‐Based Strategies
Lipids · 2026-11 · 61 (6) · 699-719
DOI: 10.1002/lipd.70069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Lipids, online erschienen am 18.06.2026. Verfasst von An Gie Ooi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health and Medical Sciences, School of Pharmacy, Taylor's University, Subang Jaya, Malaysia. Hauptthemen laut MEDLINE: Tocotrienols, Drug Delivery Systems. Die Arbeit nennt 136 Literaturangaben. Gefördert von: Taylor's University, Taylor’s University.
Abstract (Originalsprache)
Tocotrienols (T3), vitamin E analogues with potent antioxidant and therapeutic properties, have attracted increasing scientific interest. However, their clinical translation is hindered by poor and variable oral bioavailability. This limitation arises from their low aqueous solubility, rapid elimination, chemical instability and weak affinity for α‐tocopherol transfer protein, which restricts systemic retention and tissue distribution. The intestinal absorption of T3 is a saturable, concentration‐dependent process mediated primarily by Niemann–Pick C1‐like 1 and, to a lesser extent, scavenger receptor class B type 1. This review outlines the pharmacokinetics of T3 and critically examines recent advances in oral delivery systems aimed at improving bioavailability. While existing approaches offer improvement in bioavailability, intrinsic absorption barriers remain a challenge. Future progress requires integrating both physicochemical and biological strategies, focusing on modulating intestinal transporters and controlling the release kinetics to mitigate local saturation. Such next‐generation formulations may enable consistent absorption, prolonged circulation, and enhanced therapeutic efficacy of T3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health and Medical Sciences, School of Pharmacy, Taylor's University, Subang Jaya, Malaysia.
- School of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town, Penang, Malaysia.
- Digital Health and Medical Advancements Impact Lab, Taylor's University, Subang Jaya, Selangor, Malaysia.
- Centre for Active Living, Taylor's University, Subang Jaya, Selangor, Malaysia.
ORCID-Profile: An Gie Ooi, Chee Chin Chu
Förderung
- Taylor's University
- Taylor’s University
Zitieren
APA
Ooi, A. G., Yuen, K. H., Chu, C. C., & Wong, J. W. (2026). Oral Delivery of Tocotrienols: Addressing Pharmacokinetic Challenges With Formulation‐Based Strategies. Lipids, 61(6), 699-719. https://doi.org/10.1002/lipd.70069
Vancouver
Ooi AG, Yuen KH, Chu CC, Wong JW. Oral Delivery of Tocotrienols: Addressing Pharmacokinetic Challenges With Formulation‐Based Strategies. Lipids. 2026;61(6):699-719. doi:10.1002/lipd.70069
BibTeX
@article{Ooi2026,
author = {Ooi, An Gie and Yuen, Kah Hay and Chu, Chee Chin and Wong, Jia Woei},
title = {Oral Delivery of Tocotrienols: Addressing Pharmacokinetic Challenges With Formulation‐Based Strategies},
journal = {Lipids},
year = {2026},
volume = {61},
number = {6},
pages = {699--719},
doi = {10.1002/lipd.70069}
}
EUVIMED